The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1492
April 11, 2016
View Complete Issue         Table of Contents 2019 
Buprenorphine Buccal Film (Belbuca) for Chronic Pain
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Buprenorphine Buccal Film (Belbuca) for Chronic Pain
April 11, 2016 (Issue: 1492)
Belbuca (Endo), a buccal formulation of the partial opioid agonist buprenorphine, has been approved by the FDA for management of pain severe enough to require daily, around-the-clock, long-term opioid treatment. Buprenorphine is also available as...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Buprenorphine Buccal Film (Belbuca) for Chronic Pain
Article code: 1492b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.